Literature DB >> 34164431

Glycans in Virus-Host Interactions: A Structural Perspective.

Nathaniel L Miller1,2,3, Thomas Clark2,3, Rahul Raman2,3, Ram Sasisekharan2,3.   

Abstract

Many interactions between microbes and their hosts are driven or influenced by glycans, whose heterogeneous and difficult to characterize structures have led to an underappreciation of their role in these interactions compared to protein-based interactions. Glycans decorate microbe glycoproteins to enhance attachment and fusion to host cells, provide stability, and evade the host immune system. Yet, the host immune system may also target these glycans as glycoepitopes. In this review, we provide a structural perspective on the role of glycans in host-microbe interactions, focusing primarily on viral glycoproteins and their interactions with host adaptive immunity. In particular, we discuss a class of topological glycoepitopes and their interactions with topological mAbs, using the anti-HIV mAb 2G12 as the archetypical example. We further offer our view that structure-based glycan targeting strategies are ready for application to viruses beyond HIV, and present our perspective on future development in this area.
Copyright © 2021 Miller, Clark, Raman and Sasisekharan.

Entities:  

Keywords:  2G12; glycans; glycoepitope; topology; virus

Year:  2021        PMID: 34164431      PMCID: PMC8215384          DOI: 10.3389/fmolb.2021.666756

Source DB:  PubMed          Journal:  Front Mol Biosci        ISSN: 2296-889X


  100 in total

1.  HIV-1: nature's master of disguise.

Authors:  John R Mascola; David C Montefiori
Journal:  Nat Med       Date:  2003-04       Impact factor: 53.440

2.  Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.

Authors:  Daniel A Calarese; Hing-Ken Lee; Cheng-Yuan Huang; Michael D Best; Rena D Astronomo; Robyn L Stanfield; Hermann Katinger; Dennis R Burton; Chi-Huey Wong; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-07       Impact factor: 11.205

3.  Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.

Authors:  Julian K-C Ma; Jürgen Drossard; David Lewis; Friedrich Altmann; Julia Boyle; Paul Christou; Tom Cole; Philip Dale; Craig J van Dolleweerd; Valerie Isitt; Dietmar Katinger; Martin Lobedan; Hubert Mertens; Mathew J Paul; Thomas Rademacher; Markus Sack; Penelope A C Hundleby; Gabriela Stiegler; Eva Stoger; Richard M Twyman; Brigitta Vcelar; Rainer Fischer
Journal:  Plant Biotechnol J       Date:  2015-07-03       Impact factor: 9.803

Review 4.  Structural principles controlling HIV envelope glycosylation.

Authors:  Anna-Janina Behrens; Max Crispin
Journal:  Curr Opin Struct Biol       Date:  2017-03-29       Impact factor: 6.809

5.  N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.

Authors:  Xiangjie Sun; Akila Jayaraman; Pavithra Maniprasad; Rahul Raman; Katherine V Houser; Claudia Pappas; Hui Zeng; Ram Sasisekharan; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

6.  Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges.

Authors:  Margaret E Huflejt; Marko Vuskovic; Daniela Vasiliu; Hongyu Xu; Polina Obukhova; Nadezhda Shilova; Alexander Tuzikov; Oxana Galanina; Banu Arun; Karen Lu; Nicolai Bovin
Journal:  Mol Immunol       Date:  2009-07-15       Impact factor: 4.407

7.  Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.

Authors:  Juan A Mondotte; Pierre-Yves Lozach; Ali Amara; Andrea V Gamarnik
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

8.  Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.

Authors:  Jeffrey E Lee; Marnie L Fusco; Ann J Hessell; Wendelien B Oswald; Dennis R Burton; Erica Ollmann Saphire
Journal:  Nature       Date:  2008-07-10       Impact factor: 49.962

9.  GLYCAM06: a generalizable biomolecular force field. Carbohydrates.

Authors:  Karl N Kirschner; Austin B Yongye; Sarah M Tschampel; Jorge González-Outeiriño; Charlisa R Daniels; B Lachele Foley; Robert J Woods
Journal:  J Comput Chem       Date:  2008-03       Impact factor: 3.376

10.  A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site.

Authors:  Nicholas C Wu; Andrew J Thompson; Jia Xie; Chih-Wei Lin; Corwin M Nycholat; Xueyong Zhu; Richard A Lerner; James C Paulson; Ian A Wilson
Journal:  Nat Commun       Date:  2018-03-28       Impact factor: 14.919

View more
  4 in total

Review 1.  Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies.

Authors:  Nathaniel L Miller; Rahul Raman; Thomas Clark; Ram Sasisekharan
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 2.  SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection.

Authors:  Irena Trbojević-Akmačić; Tea Petrović; Gordan Lauc
Journal:  Glycoconj J       Date:  2021-09-20       Impact factor: 2.916

3.  Conserved topology of virus glycoepitopes presents novel targets for repurposing HIV antibody 2G12.

Authors:  Nathaniel L Miller; Vidya Subramanian; Thomas Clark; Rahul Raman; Ram Sasisekharan
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379

4.  Breathing and tilting: mesoscale simulations illuminate influenza glycoprotein vulnerabilities.

Authors:  Lorenzo Casalino; Christian Seitz; Julia Lederhofer; Yaroslav Tsybovsky; Ian A Wilson; Masaru Kanekiyo; Rommie E Amaro
Journal:  bioRxiv       Date:  2022-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.